PASITHEA THERAPEUTICS CORP. Share-based Payment Arrangement, Expense
PASITHEA THERAPEUTICS CORP. (KTTA) reported Share-based Payment Arrangement, Expense of $329.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $329.00K, a 467.24% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $138.00K, a 42.27% increase year-over-year.
- PASITHEA THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $58.00K, a 57.04% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $97.00K, a 67.45% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. share-based payment arrangement, expense for fiscal 2023 was $72.00K.
- PASITHEA THERAPEUTICS CORP. share-based payment arrangement, expense for fiscal 2021 was $641.18K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $329.00K 10-Q · filed 2026-08-14 | $467.00K derived: sum of 2 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $138.00K 10-Q · filed 2026-05-15 | ||||
| 2025-06-30 | $58.00K 10-Q · filed 2026-08-14 | $155.00K derived: sum of 2 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $97.00K 10-Q · filed 2026-05-15 | ||||
| 2024-09-30 | $121.00K 10-Q · filed 2024-11-13 | $256.00K derived: sum of 2 quarters · filed 2024-11-13 | $554.00K derived: sum of 3 quarters · filed 2025-05-15 | ||
| 2024-06-30 | $135.00K 10-Q · filed 2024-08-13 | $433.00K derived: sum of 2 quarters · filed 2025-05-15 | |||
| 2024-03-31 | $298.00K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $72.00K 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | $102.00K 10-Q · filed 2024-11-13 | $297.00K derived: sum of 2 quarters · filed 2024-11-13 | $450.00K derived: sum of 3 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $195.00K 10-Q · filed 2024-08-13 | $24.00K 10-Q · filed 2023-08-11 | $48.00K 10-Q · filed 2023-08-11 | ||
| 2023-03-31 | $153.00K 10-Q · filed 2024-05-14 | $24.00K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $641.18K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |